Heyman Richard A. sold 3,200 shares of Oric Pharmaceuticals, Inc. at $12.91 for −$41.3k on Oct 1, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$41,325.12Shares × reported price
Shares traded
3,200Common Stock
Price per share
$12.91Reported price. Read footnotes for ranges.
% of reported position traded
1.55%This security and ownership context
Holdings after
203,472Indirect · See footnote
Trade date
Oct 1, 2026Sell
Filed
Oct 2, 2026, 5:50 PM ET1-day reporting delay
Accession
0001584759-26-000017Code S · Transaction 235635
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 206,672 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Option exercise3,500$1.60$5,600Trade 235633
Oct 1, 2026Sell3,500$12.91−$45,199.35Trade 235634
Oct 1, 2026Option exercise3,500$0.00$0Trade 235636
4 transaction rows in this filing. Joint filers share the same rows.

ORIC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ORIC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +5.6%1w ago +7.9%1d ago +10%
Returns since7d −1.8%30d −24%90d180d1y

Footnotes in full

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. F2: This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. F4: The shares subject to the option are fully vested and immediately exercisable.